2m 2m 2m 2m 2m 2m 2m
Acadia Pharma (ACAD)
NASDAQ
$22.58+$0.49 (+2.22%)
Price as of Jun 23, 2026 3:10 PM EDT- $3.8BMarket Cap
- -1.73%1-Year Change
- BiotechnologyIndustry
Acadia Pharma (ACAD)
$22.58+$0.49 (+2.22%)
ACAD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $22.09 | ||
Change | +$0.47 (+2.17%) | ||
Open | $21.64 | ||
High | $22.46 | ||
Low | $21.59 | ||
Previous Close | $21.62 | ||
Volume | 1,904,396 | ||
30-Day Average Volume | 1,272,474 | ||
1-Week Change | 3.88% | ||
1-Month Change | 4.69% | ||
1-Year Change | -1.73% | ||
3-Year Change | -8.11% | ||
5-Year Change | -11.21% | ||
Fundamentals | |||
Shares Outstanding | 171.2M | ||
Total Assets | $1.6B | ||
Market Cap | $3.8B | ||
Enterprise Value | $3.5B | ||
Period: QTR TTM FY | |||
Revenue | $268.1M | ||
Net Income | $3.6M | ||
Free Cash Flow | $28.8M | ||
EBIT | $4.0M | ||
EBITDA | $6.7M | ||
Net Working Capital | $790.5M | ||
EPS | $0.02 | ||
Enterprise Value/EBITDA | 522 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 3 | ||
P/E | 1,105 | ||
PEG | -11 | ||
Price/Free Cash Flow | 131 | ||
Price/Operating Cash Flow | 111 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue